- Home
- VHC vs DYAI Comparison
VHC vs DYAI Comparison
Compare VHC & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VHC
- DYAI
- Stock Information
- Founded
- VHC 2005
- DYAI 1979
- Country
- VHC United States
- DYAI United States
- Employees
- VHC N/A
- DYAI N/A
- Industry
- VHC Multi-Sector Companies
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VHC Miscellaneous
- DYAI Health Care
- Exchange
- VHC Nasdaq
- DYAI Nasdaq
- Market Cap
- VHC 35.7M
- DYAI 29.6M
- IPO Year
- VHC 1999
- DYAI 2004
- Fundamental
- Price
- VHC $7.55
- DYAI $0.91
- Analyst Decision
- VHC
- DYAI Strong Buy
- Analyst Count
- VHC 0
- DYAI 1
- Target Price
- VHC N/A
- DYAI $6.00
- AVG Volume (30 Days)
- VHC 20.3K
- DYAI 38.9K
- Earning Date
- VHC 08-13-2025
- DYAI 08-12-2025
- Dividend Yield
- VHC N/A
- DYAI N/A
- EPS Growth
- VHC N/A
- DYAI N/A
- EPS
- VHC N/A
- DYAI N/A
- Revenue
- VHC $3,000.00
- DYAI $3,554,344.00
- Revenue This Year
- VHC N/A
- DYAI $22.56
- Revenue Next Year
- VHC N/A
- DYAI $30.95
- P/E Ratio
- VHC N/A
- DYAI N/A
- Revenue Growth
- VHC N/A
- DYAI 57.59
- 52 Week Low
- VHC $3.68
- DYAI $0.91
- 52 Week High
- VHC $13.89
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- VHC 41.62
- DYAI 37.33
- Support Level
- VHC $7.60
- DYAI $0.95
- Resistance Level
- VHC $9.05
- DYAI $1.03
- Average True Range (ATR)
- VHC 1.24
- DYAI 0.07
- MACD
- VHC -0.16
- DYAI 0.00
- Stochastic Oscillator
- VHC 12.94
- DYAI 1.25
About VHC VirnetX Holding Corp
VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.